Work

Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer

Year: 2011

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.36.8134

Authors: Susan M. Domchek, Gillian Mitchell, Geoffrey J. Lindeman, Nadine M. Tung, Judith Balmaña, Steven J. Isakoff, Rita Schmutzler, M. William Audeh, Niklas Loman, Clare Scott, Michael Friedlander, Bella Kaufman, Judy E. Garber, Andrew Tutt, Mark E. Robson

Institutions: University of Pennsylvania, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Beth Israel Deaconess Medical Center, Vall d'Hebron Hospital Universitari, Massachusetts General Hospital, University of Cologne, Cedars-Sinai Medical Center, Skåne University Hospital, Prince of Wales Hospital, Sheba Medical Center, Dana-Farber Cancer Institute, Guy's Hospital, Kings Health Partners, Memorial Sloan Kettering Cancer Center

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2167291900

FWCI: 1.461

Cites: 16

Cited by: 23

Related to: 10